Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:01 AM
Ignite Modification Date:
2025-12-25 @ 1:01 AM
NCT ID:
NCT00904293
Eligibility Criteria:
Inclusion Criteria:
* Adults ≥18 years old
* Patients who are beginning warfarin for a variety of diseases or conditions that require long-term oral anticoagulation with target INR \> 2.0 for at least 3 months
* Subjects that will be following up in UNC anticoagulation clinics at the Ambulatory Care Center or the Family Medicine Center
Exclusion Criteria:
* Patients who are unable to complete the study materials (questionnaires) with or without assistance (for example, those with dementia)
* Non-English speaking patients
* Patients who are being started on anticoagulation intended to last \< 3 months or whose target INR is \< 2.0
* Patients who have a history of treatment with warfarin and a known dose requirement will be excluded (as they should be restarted on the previous dose)
* Pregnant women will be excluded because warfarin is a teratogen and pregnant women should not take the medication
* Patients will also be excluded if their treating physician does not agree to use the recommended INR dose or feels that the patient should not be enrolled in the study
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00904293
Study Brief:
Protocol Section:
NCT00904293